The Effects of Hypomethylating Agents on Mutational Profiles in Patients with Myelodysplastic Syndromes

被引：0
|
作者：
Qiu, Jihui [1 ]
Velu, Priya [2 ]
Rosenbaum, Jason [3 ]
Babushok, Daria [2 ]
Bagg, Adam [2 ]
机构：
[1] Jefferson Hlth New Jersey, Cherry Hill, NJ USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] UPenn, Ctr Personalized Diagnost, Philadelphia, PA USA
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1363
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agents
    Jabbour, Elias
    Strati, Paolo
    Cabrero, Monica
    O'Brien, Susan
    Ravandi, Farhad
    Bueso-Ramos, Carlos
    Wei, Qiao
    Hu, Jianhua
    Abi Aad, Simon
    Short, Nicholas J.
    Dinardo, Courtney
    Daver, Naval
    Kadia, Tapan
    Wierda, William
    Wei, Yue
    Colla, Simona
    Borthakur, Gautam
    Cortes, Jorge
    Estrov, Zeev
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (04) : 351 - 358
  • [42] Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence
    Nazha, Aziz
    Sekeres, Mikkael A.
    Bejar, Rafael
    Rauh, Michael J.
    Othus, Megan
    Komrokji, Rami S.
    Barnard, John
    Hilton, Cameron B.
    Kerr, Cassandra M.
    Steensma, David P.
    DeZern, Amy
    Roboz, Gail
    Garcia-Manero, Guillermo
    Erba, Harry
    Ebert, Benjamin L.
    Maciejewski, Jaroslaw P.
    [J]. JCO PRECISION ONCOLOGY, 2019, 3
  • [43] Efficacy and Safety of Bemcentinib in Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Failing Hypomethylating Agents
    Kubasch, Anne Sophie
    Peterlin, Pierre
    Cluzeau, Thomas
    Gotze, Katharina S.
    Sockel, Katja
    Teipel, Raphael
    Jentzsch, Madlen
    Kayser, Sabine
    Attalah, Habiba
    Chermat, Fatiha
    Gloaguen, Silke
    Jersemann, Katja
    Schipp, Dorothea
    Giagounidis, Aristoteles
    McPherson, Stuart
    Tirado-Gonzalez, Irene
    van de Loosdrecht, Arjan
    Fenaux, Pierre
    Platzbecker, Uwe
    Medyouf, Hind
    Ades, Lionel
    [J]. BLOOD, 2020, 136
  • [44] A real-world experience of venetoclax combined with hypomethylating agents vs. monotherapy hypomethylating agents in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia patients
    Zhang, Ludan
    Ge, Rui
    Pan, Deng
    Yue, Pengjie
    Zhang, Jingwen
    Bian, Renjie
    Yan, Xiaojing
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [45] Correlation of Mutational Profiles and Cytogenetics with Morphologic Dysplasia in Myelodysplastic Syndromes
    Kumar, Jyoti
    Khanna, Vishesh
    Lu, Rong
    Stehr, Henning
    Spinner, Michael A.
    Silva, Oscar
    Fernandez-Pol, Sebastian
    Oak, Jean S.
    Greenberg, Peter L.
    Tan, Brent
    [J]. BLOOD, 2022, 140 : 4053 - 4055
  • [46] Mutational Landscape in Pediatric Patients with Myelodysplastic Syndromes
    An, W.
    Chao, L.
    Yang, W.
    Xiaofan, Z.
    [J]. PEDIATRIC BLOOD & CANCER, 2018, 65 : S18 - S18
  • [47] Hypomethylating agents in myelodysplastic syndromes changing the inevitable: the value of azacitidine as maintenance therapy, effects on transfusion and combination with other agents
    Silverman, Lewis R.
    [J]. LEUKEMIA RESEARCH, 2009, 33 : S18 - S21
  • [48] Practical Recommendations for Hypomethylating Agent Therapy of Patients With Myelodysplastic Syndromes
    Steensma, David P.
    Stone, Richard M.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 24 (02) : 389 - +
  • [49] Clinicopathologic Predictors of Hypomethylating Agent Failure in Patients with Myelodysplastic Syndromes
    Chien, Kelly S.
    Urrutia, Samuel
    Li, Ziyi
    Kanagal-Shamanna, Rashmi
    Abdelhakeem, Ahmed
    Abuasab, Tareq
    Almanza, Emmanuel
    Gener-Ricos, Georgina
    Bataller, Alex
    Bazinet, Alexandre
    Montalban-Bravo, Guillermo
    Short, Nicholas J.
    Jabbour, Elias
    Kadia, Tapan M.
    Ravandi, Farhad
    Borthakur, Gautam
    Hammond, Danielle E.
    Swaminathan, Mahesh
    Sasaki, Koji
    Dong, Xiao Qin
    Pierce, Sherry
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    [J]. BLOOD, 2023, 142
  • [50] Treatment of Higher-Risk Myelodysplastic Syndromes After Failure of Hypomethylating Agents
    Komrokji, Rami S.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S56 - S59
12345